Respiratory disease diagnostics refer to methods and procedures used to identify and diagnose various respiratory diseases. Some common respiratory diseases include asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and tuberculosis, among others. According to the latest research, the global respiratory disease diagnostics market is poised to grow by USD 4.4 billion during 2023-2029, progressing at a CAGR of 7.74% during the forecast period.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global respiratory disease diagnostics market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, test type, disease, end user, and region. The global market for respiratory disease diagnostics can be segmented by product: assays and reagents, instruments and devices, services and software. The instruments and devices segment held the largest share of the global respiratory disease diagnostics market in 2022 and is anticipated to hold its share during the forecast period. Respiratory disease diagnostics market is further segmented by test type: imaging tests, in-vitro diagnostics tests, mechanical tests. Globally, the imaging tests segment made up the largest share of the respiratory disease diagnostics market. Based on disease, the respiratory disease diagnostics market is segmented into: asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, others. The COPD segment was the largest contributor to the global respiratory disease diagnostics market in 2022. On the basis of end user, the respiratory disease diagnostics market also can be divided into: hospitals and clinics, reference laboratories, others. The hospitals and clinics segment is estimated to account for the largest share of the global respiratory disease diagnostics market. Respiratory disease diagnostics market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global respiratory disease diagnostics market in 2022 and is anticipated to hold its share during the forecast period.

Market Segmentation
By product: assays and reagents, instruments and devices, services and software
By test type: imaging tests, in-vitro diagnostics tests, mechanical tests
By disease: asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, others
By end user: hospitals and clinics, reference laboratories, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The global respiratory disease diagnostics market report offers detailed information on several market vendors, including Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., CAREstream Medical Ltd., COSMED S.r.l, F. Hoffmann- La Roche AG, Koninklijke Philips N.V., Medtronic plc, MGC Diagnostics Corporation, SDI Diagnostics Inc., Seegene, Inc., Thermo Fisher Scientific Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global respiratory disease diagnostics market.
• To classify and forecast the global respiratory disease diagnostics market based on product, test type, disease, end user, region.
• To identify drivers and challenges for the global respiratory disease diagnostics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global respiratory disease diagnostics market.
• To identify and analyze the profile of leading players operating in the global respiratory disease diagnostics market.

Why Choose This Report
• Gain a reliable outlook of the global respiratory disease diagnostics market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.